Possibility of Non-Immunosuppressive Immunophilin Ligands as Potential Therapeutic Agents for Parkinson's Disease

E-ISSN： 1873-4286|10|6|669-677

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.6, 2004-02, pp. : 669-677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic targets for Parkinson's disease

By Stoessl Jon

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 425-436

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 6, 2003-12 ,pp. : 349-356

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Nerve Growth Factors in Parkinson's Disease

By Collier T.J. Sortwell C.E.

Drugs & Aging, Vol. 14, Iss. 4, 1999-04 ,pp. : 261-287

Adis International

Access to resources Recommend Favorite

Adenosine Receptor Ligands: Potential as Therapeutic Agents in Asthma and COPD

By Fozard J.R. Hannon J.P.

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 111-114

Academic Press

Access to resources Recommend Favorite

Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease

Current Bioactive Compounds, Vol. 4, Iss. 3, 2008-10 ,pp. : 150-158

Bentham Science Publishers

Access to resources Recommend Favorite